Price
Financials
Standalone, Rs crore| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.18 | 0.24 | 0.06 | 0.00 |
| Expenses | 0.00 | 0.00 | 0.00 | 0.14 | 0.00 | 0.01 | 0.05 | 0.68 | 0.10 | 0.14 | 0.04 | 0.08 |
| Operating Profit | 0.00 | 0.00 | 0.00 | -0.14 | 0.00 | -0.01 | -0.05 | -0.49 | 0.08 | 0.10 | 0.02 | -0.08 |
| OPM % | -257.89% | 44.44% | 41.67% | 33.33% | ||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.03 | 0.59 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.00 | 0.00 | -0.14 | 0.00 | -0.01 | -0.05 | -0.49 | 0.05 | 0.05 | -0.01 | -0.67 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 20.00% | 20.00% | 0.00% | -4.48% | ||||
| Net Profit | 0.00 | 0.00 | 0.00 | -0.14 | 0.00 | -0.01 | -0.05 | -0.49 | 0.04 | 0.04 | -0.01 | -0.65 |
| EPS in Rs | 0.00 | 0.00 | 0.00 | -0.20 | 0.00 | -0.01 | -0.07 | -0.70 | 0.06 | 0.06 | -0.01 | -0.93 |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.12 | 0.15 | 0.05 | 0.06 | 1.50 | 0.53 | 0.70 | 0.00 | 0.00 | 0.00 | 0.19 | 0.48 |
| Expenses | 0.27 | 0.16 | 0.05 | 0.06 | 1.50 | 0.53 | 0.70 | 0.00 | 0.00 | 0.14 | 0.74 | 7.07 |
| Operating Profit | -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -6.59 |
| OPM % | -125.00% | -6.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -289.47% | -1,372.92% | |||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.59 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -7.18 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||||
| Net Profit | -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -7.18 |
| EPS in Rs | -0.21 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.20 | -0.79 | -10.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -11% | % | % | 153% | ||
| Compounded Profit Growth | % | % | % | -1205% | ||
| Stock Price CAGR | % | % | % | 7% | ||
| Return on Equity | % | -28% | -52% | -310% |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 |
| Reserves | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.41 | -0.41 | -0.55 | -1.10 | -8.27 |
| Borrowings | 0.14 | 0.12 | 0.12 | 0.12 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 5.44 | 1.66 |
| Other Liabilities | 0.00 | -0.01 | -0.01 | -0.01 | 1.46 | 1.90 | 2.60 | 3.11 | 3.11 | 3.25 | 3.57 | 0.37 |
| Total Liabilities | 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 0.76 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 0.76 |
| Total Assets | 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 0.76 |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1.00 | 0.00 | 0.00 | 0.97 | -0.03 | -0.02 | 0.13 | 0.00 | 0.00 | 0.00 | -4.59 | 4.42 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | -0.91 | 0.00 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activity | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.58 | -4.38 |
| Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.06 | -0.03 | -0.02 | 0.05 | 0.00 | 0.00 | 0.00 | -0.01 | 0.04 |
| Free Cash Flow | 1.00 | 0.00 | 0.00 | 0.97 | -0.03 | -0.02 | 0.13 | 0.00 | 0.00 | 0.00 | -4.59 | 4.42 |
| CFO/OP | -667% | 0% | 0% | 835% | -67% |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 362.57 | 1,342.92 | 1,308.79 | 5,532.63 | 0.00 | |||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 11.59 | 0.00 | ||||||
| Days Payable | 1,488.97 | |||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 362.57 | 1,342.92 | -168.60 | 5,532.63 | 0.00 | |||
| Working Capital Days | -425.83 | -292.00 | -876.00 | 4,745.00 | 226.30 | 661.13 | 453.64 | 10,585.00 | 235.73 | |||
| ROCE % | -2.05% | -0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.89% | -5.89% | -112.36% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.70% | 1.70% |
| Public | 97.85% | 97.85% | 97.86% | 97.86% | 97.86% | 97.86% | 97.85% | 97.85% | 97.86% | 97.85% | 96.14% | 96.15% |
| No. of Shareholders | 1,141 | 1,141 | 1,141 | 1,141 | 1,141 | 1,141 | 1,147 | 1,295 | 1,385 | 1,410 | 1,408 | 1,447 |
Fundamentals
Market Cap₹ 6.13 Cr.
Current Price₹ 8.76
Book Value₹ -1.81
ROCE-112 %
ROE-310 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)153%
Compounded Profit Growth (TTM)-1205%
Standalone figures.
Valuation
Market capRs 7 Cr
Enterprise valueRs 9 Cr
Price to book-5.58x
Price to sales14.76x
EV / EBITDA72.22x
EV / EBIT72.22x
EV / sales18.05x
Price to cash flow1.60x
Earnings yield-8.18%
P/B, 3-year average-0.20x
P/B, 5-year average0.59x
Profitability
Operating margin (excl. other income)-1372.92%
Operating margin (incl. other income)-1372.92%
EBITDA margin25.00%
Pre-tax margin-120.83%
Net profit margin-120.83%
ROE-310.15%
ROCE-112.36%
ROA-91.64%
ROE, 3-year average-107.07%
ROCE, 3-year average-40.05%
ROA, 3-year average-32.43%
ROE, 5-year average-107.07%
ROCE, 5-year average-40.05%
ROA, 5-year average-32.43%
ROIC (approx.)38.71%
Growth
Sales growth (latest year)152.63%
Sales CAGR, 3 years-11.82%
Sales CAGR, 5 years-20.38%
Per share
EPS (TTM)Rs -0.83
EPS (latest year)Rs -10.25
EPS (latest quarter)Rs -0.93
EPS, 3-year averageRs -3.75
EPS, 5-year averageRs -3.75
Book value per shareRs -1.81
Sales per shareRs 0.69
Cash flow per shareRs 6.31
Free cash flow per shareRs 6.31
Efficiency
Asset turnover0.63x
Creditor days1489 days
Cash conversion cycle0 days
Working capital days236 days
Leverage
Total debtRs 2 Cr
Cash and bankRs 0 Cr
Net debtRs 2 Cr
Debt to equity-1.31x
Net debt / EBITDA13.17x
Interest coverage0.17x
Owners' fund to total sources-167.11%
Debt to assets218.42%
Cash flow
Cash from Operating Activity (latest year)Rs 4 Cr
Cash from Financing Activity (latest year)Rs -4 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 4 Cr
FCFE (approx.: FCF + change in debt)Rs 1 Cr
Sales to cash flow0.11x
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -7 Cr
Operating profit (latest quarter)Rs -0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -1 Cr
Net profit (TTM)Rs -1 Cr
Net profit (latest year)Rs -7 Cr
Net profit (latest quarter)Rs -1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 7 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 7 Cr
ReservesRs -8 Cr
Shareholders' fundsRs -1 Cr
Total assetsRs 1 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)0.70
Ownership
Promoter holding2.14% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | 531458 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +27.1% | -2.8% | +29.9 pts |
| 1 month | +120.5% | -6.8% | +127.3 pts |
| 3 months | +68.4% | -7.6% | +76.0 pts |
| 3 years | -39.6% | +14.2% | -53.8 pts |
| 5 years | -39.6% | +27.9% | -67.5 pts |
Red flags
F-score 4 of 8| serious | Negative equity Shareholders' equity is negative |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹0 Cr -100.0% vs Mar 2025.
Net loss ₹1 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Boston Commerce Limited?
Boston Commerce Limited (531458) has a market capitalisation of Rs 6.13 Cr. at the 2026-10-01 close.
What were Boston Commerce Limited's latest quarterly results?
In the Mar 2026 quarter, Boston Commerce Limited sales was Rs 0 Cr (-100.0% vs Mar 2025) with a net loss of Rs 1 Cr.